UC Berkeley spinout Iota Biosciences has obtained $15m in series A capital from investors including Astellas.
Iota Biosciences, a US-based medical device manufacturer spun out of University of California (UC) Berkeley, has closed a $15m series A round backed by investors including pharmaceutical firm Astellas.
Horizons Ventures, Bold Capital Partners, Ironfire and Shanda also supplied capital. The round closed in May 2018, but details were only revealed last week.
Founded in 2017, Iota Biosciences is working on implantable bioelectronic devices, called neural dust, that are the size of a grain of sand.
The…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
